GyroGlove, a wearable device, for hand tremor in essential tremor
Tests the GyroGlove device for steadying hand tremor in adults with essential tremor.
Key facts
- Who runs it
- GyroGear Ltd
- Where
- Burlington, Farmington Hills, and Houston, United StatesSee the 3 sitesAlso in 1 other country, 4 sites
- Trial code
- Registry title
- GyroGlove Use in Essential Tremor Patients
- Status
- Not yet recruiting
- People taking part
- 30 people, planned
- Started
- Jul 2025
- Planned end
- Dec 2025
- Type of study
- Interventional, 3 groupsOne group gets a placebo (a dummy treatment), for comparison.
- Treatments tested
- Placebo
- GyroGlove
- Record updated
- 14 March 2025
Who can take part
AI summary
From the trial's eligibility criteria. Machine-read from the registry text on this page, so it can be wrong. The registry text below and the trial team decide who can take part.
The trial is looking for adults with essential tremor whose hand shaking makes them spill water when drinking. It tests a glove called GyroGlove meant to steady hand tremor.
- Age
- 18 years or older
- Sex
- All sexes
- Disease stage
- Clinically diagnosed essential tremor (ET) in one or both hands, or mainly the hand and forearm. A score of ≥ 2 in ADL activities 2, 3, 6 & 8 of the TETRAS ADL subscale. Tremor in at least one hand causing water spillage when drinking.
- Earlier treatment
- Medicine doses must stay the same during the study. No change in tremor medicine within 1 month, or in antidepressants within 3 months, before joining. No botulinum toxin injection for hand tremor within 4 months. No previous thalamotomy, including gamma knife or focused ultrasound.
Main reasons for not taking part
- Tremor from other causes, such as Parkinson's disease, drugs or enhanced physiological tremor
- Implanted electrical device, such as a pacemaker, defibrillator or deep brain stimulator
- Hand or arm problems that stop wearing the glove, such as joint deformities, muscle weakness or skin conditions like eczema
- Alcohol use disorder or illicit drug use (medical cannabis allowed), or other nerve conditions, including nerve damage in the arm
- Pregnancy
The registry criteria, word for word
Show all 24 criteriaShow less
Who can take part
- 18 years of age or older
- Subject has been clinically diagnosed with ET
- Has either unilateral or bilateral tremor of the hand or predominantly hand as well as forearm
- Has a score of ≥ 2 in ADL activities 2, 3, 6 \& 8 of the TETRAS ADL subscale (TRG, Sep 2021)
- Tremor in at least one hand causing water spillage during drinking; And
- Stable dosage of medications throughout the duration of the study, if applicable
- Ability to speak and read in the language that the trial documentation has been translated to
- Ability to understand verbal instructions in the language that the trial documentation has been translated to
- Ability to provide written informed consent to participate in the study
- Capacity to complete self-report outcome measures in the language that the trial documentation has been translated to
Who cannot take part
- Change in medication for tremor within 1 month prior to study enrolment
- Change in antidepressant medication within 3 months prior to study enrolment
- Has received botulinum toxin injection for hand tremor within 4 months prior to study enrolment
- Previous thalamotomy procedure, including stereotactic thalamotomy, gamma knife radio surgical thalamotomy, and focused ultrasound for the treatment of tremor
- Other possible causes of tremor, including Parkinson's disease, drug-induced, enhanced physiological tremor
- Clinically diagnosed alcohol use disorder or illicit substance use (exception medical cannabis)
- Has been diagnosed with any of the following conditions affecting the hand and/or arm:; Fingers/Wrist joint defects or deformities or current skeletal injuries that prevent them from wearing the glove; Hand muscular deformities or weakness, e.g.: Myotonic Dystrophy, Autosomal Recessive Muscular Dystrophy limiting participant to perform required test/procedure in the study; Skin Conditions of the hand and forearm, e.g.: Eczema, Psoriasis, Extreme Skin Sensitivity; Growth or Development Defects of the hand, including but not limited to, Brittle Bone Disease, Triphalangeal Thumb
- Neurological conditions aside from essential tremor that may affect the conduct of the study
- Presence of tremor around the elbow and shoulder limiting participants to perform required test/procedure in the study
- Has implanted electrical medical device, e.g., pacemaker, defibrillator, or deep brain stimulator
- Peripheral neuropathy affecting the upper extremity
- Are participating or have participated in any interventional clinical trial or study in the last 30 days which may confound the results of this study, unless approved by the Sponsor
- Inability to follow simple instructions
- Pregnancy
Where in United States
Also in 1 other country, 4 sites
- University of Vermont Medical CentreBurlington, United StatesContact: James BoydNot yet recruiting
- QUEST Research InstituteFarmington Hills, United StatesContact: Peter LeWittNot yet recruiting
- Houston Methodist Stanley H. Appel Department of NeurologyHouston, United StatesContact: William OndoNot yet recruiting
About the trial
What the trial wants to find out
This is a multi-centre, single-blind, placebo-controlled trial with an open label follow up. After the baseline assessment, all participants will receive the GyroGlove for two weeks during the open label follow up part of the trial. All gloves will be retrieved and returned to GyroGear after closure of the study.
The 3 groups in the trial
- No InterventionalNo study treatment, for comparison
Participants will perform protocol-specific tasks with no device
- Investigational Device ArmTreatment being tested
GyroGlove
Treatment: GyroGlove
- Placebo ArmPlacebo, for comparison
Placebo
Treatment: Placebo
Questions to ask the study team
- How often do I need to come in, and for how long each time?
- Are travel costs paid?
- Can I keep my own doctor?
- What happens if I want to stop?
Contact the study team: see the registry record → Contacts and Locations
Print a page for my doctorData and sources
- Registry record
- Listed on ClinicalTrials.gov.
- Official title
- Effectiveness and Safety of GyroGlove in Stabilising Hand Tremors in Essential Tremor
- Plain-language title
- GyroGlove, a wearable device, for hand tremor in essential tremorGenerated from the registry record. The registry title is the official one.
- AI summary
- From the trial's eligibility criteria. Read by machine on 14 November 2026.
- Record updated
- 14 March 2025